Peripheral Nerve Stimulation for Chronic Neuropathic Pain

Medical Necessity Assessment

The American College of Physicians recommends peripheral nerve stimulation for patients with chronic intractable pain who have failed multiple medications, including baclofen, gabapentin, opioid analgesics, and anti-inflammatory medications 1, 2
Patients with chronic neuropathic pain conditions, such as causalgia, may be eligible for peripheral nerve stimulation if they have demonstrated a significant response to a trial period, with improved physical function and daily activities 3

The American Academy of Neurology recognizes peripheral nerve stimulation as an effective treatment for chronic neuropathic pain conditions, including causalgia and complex regional pain syndrome, when conventional treatments have failed 2, 3

The American College of Surgeons notes that while peripheral nerve stimulation can provide significant pain relief, some patients may experience diminishing effectiveness over time, highlighting the need for regular follow-up 1
Hardware-related complications, such as lead migration, connection issues, and infection risk, should be discussed with the patient, with reported rates ranging from 10-29% of cases 2
The patient's medication regimen should continue to be monitored and potentially adjusted following implantation, according to the American Diabetes Association 4, 2

The American College of Physicians and American College of Neurosurgery require that patients with chronic intractable pain must have failed multiple conservative treatments, including documented physical therapy, appropriate medications, and objective diagnostic testing, before proceeding to permanent neurostimulation 5
Objective evidence of pathology, such as electromyography/nerve conduction studies (EMG/NCS), is essential to confirm neuropathic pain etiology and guide appropriate nerve targeting 5
Diagnostic blocks of specific affected nerves are necessary to identify pain generators and confirm that the targeted neural structures are responsible for the patient's pain 5
Recent imaging, such as T-spine and L-spine MRIs, is required to confirm ongoing pathology and rule out new structural changes that might contraindicate stimulation 5

A successful trial with at least 50% pain reduction for a minimum of 3 days is necessary, but not sufficient, for permanent neurostimulator implantation 5